FDA’s Summer Plans May Include LDT Rulemaking
FDA Law Blog
JUNE 19, 2023
And, of course, there is the political calendar. Opponents of LDT regulation received a boost with last year’s Supreme Court decision overturning an agency action based on the “major questions” doctrine, West Virginia v. Raimondo , FDA may also lose the shield of Chevron deference in any litigation.
Let's personalize your content